| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |